TScan Therapeutics Inc

The current institutional shareholding score of TScan Therapeutics Inc is 5.00, ranking 133 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 59.35%, representing a quarter-over-quarter decrease of 20.68%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.27% of shares outstanding, with 1.58% increase in holdings.